MoneyWorks4Me

Lupin reports 9% rise in Q2 consolidated net profit

23 Oct 2012 Evaluate

Lupin has reported results for second quarter ended September 30, 2012. 

The company has reported a rise of 20.07% in its net profit at Rs 321.94 crore for the quarter ended September 30, 2012 as compared to Rs 268.12 crore for the same quarter in the previous year. Total income from operation has increased by 24.79% at Rs 1756.70 crore for quarter under review as compared to Rs 1407.73 crore for the quarter ended September 30, 2011.

On consolidated basis, the company has posted a rise of 8.84% in its net profit after tax and minority interest at Rs 290.46 crore for the quarter ended September 30, 2012 as compared to Rs 266.86 crore for the same quarter in the previous year. Total income from operation has increased by 29.93% at Rs 2305.00 crore for quarter under review as compared to Rs 1774.10 crore for the quarter ended September 30, 2011.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..